Abstract
Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.
Original language | English |
---|---|
Pages (from-to) | 617-618 |
Number of pages | 2 |
Journal | Annals of Internal Medicine |
Volume | 118 |
Issue number | 8 |
State | Published - 15 Apr 1993 |
Externally published | Yes |